Home Clinical Psychology & Psychotherapy Study Finds Gut Microbiota Key to Social Anxiety, Opens Door to New Treatments

Study Finds Gut Microbiota Key to Social Anxiety, Opens Door to New Treatments

Reading Time: 2 minutes

In a pioneering study that could revolutionise the understanding and treatment of social anxiety disorder (SAD), researchers have uncovered a significant connection between the gut microbiota and increased sensitivity to social fear.

Social anxiety disorder, characterised by overwhelming anxiety in social situations, has long perplexed the medical community due to its unclear biological underpinnings and the inadequacy of existing treatments. However, the study led by Nathaniel L. Ritz and a team of international researchers has opened new avenues in understanding the role of gut microbiota in SAD.

At the heart of this study is the microbiota-gut-brain axis, a complex network that underscores the bidirectional communication between the gut and the brain. The research team, aiming to explore the causal role of gut microbiota in modulating behaviours relevant to SAD, conducted a comprehensive study involving faecal microbiota transplantation (FMT) from SAD patients to mice. This approach is based on the premise that transplanting the microbiota can elicit specific psychological traits in the recipient.

The study revealed that mice receiving the SAD patient microbiota displayed a specific increase in sensitivity to social fear, without affecting other behaviours tested. Interestingly, this heightened social fear response was accompanied by notable changes in immune function and the expression of oxytocin, a hormone and neurotransmitter often associated with social bonding and behavior, in key brain regions.

Central to the findings was the identification of altered bacteriome compositions in individuals with SAD, which were similarly reflected in the recipient mice. Notably, three bacterial species – Bacteroides nordii, Bacteroides cellulosiyticus, and Phocaeicola massiliensi – demonstrated differential abundance in the SAD and healthy control groups. This points to the potential role of specific gut bacterial populations in influencing the host’s susceptibility to social anxiety and fear.

Moreover, the study uncovered intriguing changes in immune system dynamics. Mice with SAD microbiota exhibited reduced levels of the stress hormone corticosterone, along with alterations in the immune response, including changes in cytokine production and T-cell activity. This suggests a significant immunomodulatory role of the gut microbiota in SAD.

Another critical finding was the impact of SAD-associated microbiota on brain function, particularly concerning the neurotransmitter oxytocin. In mice receiving the SAD microbiota, there was a marked reduction in oxytocin neurons in the bed nucleus of the stria terminalis (BNST), a brain region crucial in modulating social behavior and fear responses. Furthermore, changes in oxytocin and vasopressin gene expression in areas like the medial amygdala and prefrontal cortex were observed, highlighting the profound influence of the gut microbiota on neural circuits associated with social behaviour.

The results of this study emphasise the gut microbiota’s far-reaching effects on brain function and behaviour, offering novel insights into the biological mechanisms underlying social anxiety disorder. Importantly, this research opens up potential new therapeutic pathways targeting the microbiota-gut-brain axis, offering hope for more effective treatment strategies for SAD in the future.

© Copyright 2014–2034 Psychreg Ltd